Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khaled M Musallam

Showing results (31-40 of 204) with videos related to

Pageof 21
Sort By:
Hemoglobin|October 5, 2011
Cerebral infarction in children with sickle cell disease: a concise overviewKhaled M Musallam, Ruby A Khoury, Miguel R Abboud
American Journal of Hematology|May 7, 2019
Development of a thalassemia-related thrombosis risk scoring systemAli T Taher, Maria Domenica Cappellini, Khaled M Musallam
Blood Reviews|May 29, 2012
Recent advances and treatment challenges in patients with non-transfusion-dependent thalassemiaAli T Taher, Maria D Cappellini, Khaled M Musallam
Cell Reports. Medicine|October 19, 2022
Right in time: Mitapivat for the treatment of anemia in α- and β-thalassemiaKhaled M Musallam, Ali T Taher, Maria Domenica Cappellini
The New England Journal of Medicine|June 2, 2021
β-Thalassemias. ReplyAli T Taher, Khaled M Musallam, M Domenica Cappellini
Annals of Hematology|February 12, 2021
Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemiaKhaled M Musallam, Maria Domenica Cappellini, Ali T Taher
The New England Journal of Medicine|February 24, 2021
β-ThalassemiasAli T Taher, Khaled M Musallam, M Domenica Cappellini
Blood Cells, Molecules & Diseases|February 22, 2013
Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermediaKhaled M Musallam, Maria Domenica Cappellini, Ali T Taher
Current Opinion in Hematology|February 22, 2013
Iron overload in β-thalassemia intermedia: an emerging concernKhaled M Musallam, Maria D Cappellini, Ali T Taher
Cold Spring Harbor Perspectives in Medicine|July 5, 2012
β-thalassemia intermedia: a clinical perspectiveKhaled M Musallam, Ali T Taher, Eliezer A Rachmilewitz
Pageof 21

Showing results (31-40 of 204) with videos related to

Sort By:
Pageof 21
Hemoglobin|October 5, 2011
Cerebral infarction in children with sickle cell disease: a concise overviewKhaled M Musallam, Ruby A Khoury, Miguel R Abboud
American Journal of Hematology|May 7, 2019
Development of a thalassemia-related thrombosis risk scoring systemAli T Taher, Maria Domenica Cappellini, Khaled M Musallam
Blood Reviews|May 29, 2012
Recent advances and treatment challenges in patients with non-transfusion-dependent thalassemiaAli T Taher, Maria D Cappellini, Khaled M Musallam
Cell Reports. Medicine|October 19, 2022
Right in time: Mitapivat for the treatment of anemia in α- and β-thalassemiaKhaled M Musallam, Ali T Taher, Maria Domenica Cappellini
The New England Journal of Medicine|June 2, 2021
β-Thalassemias. ReplyAli T Taher, Khaled M Musallam, M Domenica Cappellini
Annals of Hematology|February 12, 2021
Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemiaKhaled M Musallam, Maria Domenica Cappellini, Ali T Taher
The New England Journal of Medicine|February 24, 2021
β-ThalassemiasAli T Taher, Khaled M Musallam, M Domenica Cappellini
Blood Cells, Molecules & Diseases|February 22, 2013
Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermediaKhaled M Musallam, Maria Domenica Cappellini, Ali T Taher
Current Opinion in Hematology|February 22, 2013
Iron overload in β-thalassemia intermedia: an emerging concernKhaled M Musallam, Maria D Cappellini, Ali T Taher
Cold Spring Harbor Perspectives in Medicine|July 5, 2012
β-thalassemia intermedia: a clinical perspectiveKhaled M Musallam, Ali T Taher, Eliezer A Rachmilewitz
Pageof 21